SBFM (Sunshine Biopharma) Float Percentage Of Total Shares Outstanding: 99.69% (As of Jul. 02, 2026)


SBFM Sunshine Biopharma Inc SBFM
34 GF Score
Price $2.18
GF Value $7.15
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Sunshine Biopharma Float Percentage Of Total Shares Outstanding?

Sunshine Biopharma SBFM +1.87% 34 Float Percentage Of Total Shares Outstanding is 99.69% as of Jul. 02, 2026. GuruFocus rates SBFM with a GF Score™ of 34/100 and a GF Value™ of $7.15 (Possible Value Trap). The stock has 4 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sunshine Biopharma's float shares is 2.11 Mil. Sunshine Biopharma's total shares outstanding is 2.12 Mil. Sunshine Biopharma's float percentage of total shares outstanding is 99.69%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sunshine Biopharma's Insider Ownership is 24.07%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sunshine Biopharma's Institutional Ownership is 2.44%.

SBFM
34GF Score
Sunshine Biopharma Inc SBFM
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunshine Biopharma Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Sunshine Biopharma's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=2.11/2.12
=99.69%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 99.69% mean?
Sunshine Biopharma (SBFM) has a Float Percentage Of Total Shares Outstanding of 99.69% as of Jul. 02, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Sunshine Biopharma and its competitors.
Is Sunshine Biopharma's Float Percentage Of Total Shares Outstanding too high?
Sunshine Biopharma's current Float Percentage Of Total Shares Outstanding is 99.69%. Overall, Sunshine Biopharma has a GF Score™ of 34/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sunshine Biopharma's Float Percentage Of Total Shares Outstanding compare to PRFX and CTTH?
Sunshine Biopharma's Float Percentage Of Total Shares Outstanding of 99.69% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Drug Manufacturers company?
A good Float Percentage Of Total Shares Outstanding depends on the Drug Manufacturers industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Sunshine Biopharma and its competitors. Sunshine Biopharma's current Float Percentage Of Total Shares Outstanding is 99.69%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunshine Biopharma stock overvalued right now?
Based on GuruFocus' analysis, Sunshine Biopharma (SBFM) is currently considered Possible Value Trap. The stock's GF Value™ is $7.15, compared to a current price of $2.18 — trading 69.5% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 99.69%. Sunshine Biopharma's overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Sunshine Biopharma (SBFM), the current Float Percentage Of Total Shares Outstanding is 99.69% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sunshine Biopharma (SBFM) Overvalued in 2026?

Based on GuruFocus' analysis, Sunshine Biopharma stock appears to be undervalued. The current stock price of $2.18 is trading 69.5% below its estimated GF Value™ of $7.15. GuruFocus considers Sunshine Biopharma to be Possible Value Trap.

Key valuation signals for SBFM:

  • Float Percentage Of Total Shares Outstanding: 99.69%
  • GF Value™: $7.15 vs. price of $2.18 (69.5% below fair value)
  • GF Score™: 34/100 with 4 warning signs

No single metric tells the full story. See the SBFM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sunshine Biopharma Business Description

Address 333 Las Olas Way, CU4 Suite 433, Fort Lauderdale, FL, USA, 33301
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
34GF Score

Get the complete analysis for SBFM

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.18
Price
$7.15
GF Value